Skip to main content
NIH Intramural Research Program, Our Research Changes Lives

Navigation controls

  • Search
  • Menu

Social follow links

  • Podcast
  • Instagram
  • Twitter
  • YouTube
  • LinkedIn

Main navigation

  • About Us
    • What Is the IRP?
    • History
    • Honors
      • Nobel Prize
      • Lasker Award
      • Breakthrough Prize
      • Presidential Early Career Award for Scientists and Engineers (PECASE)
      • Presidential Medal of Freedom
      • National Medal of Science
      • Searle Scholars
      • The National Academy of Sciences
      • The National Academy of Medicine
      • The National Academy of Engineering
      • The American Academy of Arts and Sciences
      • National Medal of Technology & Innovation
      • Samuel J. Heyman Service to America Medals
      • Crafoord Prize
      • Fellows of the Royal Society
      • Canada Gairdner Awards
    • Organization & Leadership
    • Our Programs
      • NCI
      • NEI
      • NHGRI
      • NHLBI
      • NIA
      • NIAAA
      • NIAID
      • NIAMS
      • NIBIB
      • NICHD
      • NIDA
      • NIDCD
      • NIDCR
      • NIDDK
      • NIEHS
      • NIMH
      • NIMHD
      • NINDS
      • NINR
      • NLM
      • CC
      • NCATS
      • NCCIH
    • Research Campus Locations
    • Contact Information
  • Our Research
    • Scientific Focus Areas
      • Biomedical Engineering & Biophysics
      • Cancer Biology
      • Cell Biology
      • Chemical Biology
      • Chromosome Biology
      • Clinical Research
      • Computational Biology
      • Developmental Biology
      • Epidemiology
      • Genetics & Genomics
      • Health Disparities
      • Immunology
      • Microbiology & Infectious Diseases
      • Molecular Biology & Biochemistry
      • Molecular Pharmacology
      • Neuroscience
      • RNA Biology
      • Social & Behavioral Sciences
      • Stem Cell Biology
      • Structural Biology
      • Systems Biology
      • Virology
    • Principal Investigators
      • View by Investigator Name
      • View by Scientific Focus Area
    • Accomplishments
      • View All Accomplishments by Date
      • View All Health Topics
      • The Body
      • Health & Wellness
      • Conditions & Diseases
      • Procedures
    • Accelerating Science
      • Investing in Cutting-Edge Animal Models
      • Creating Cell-Based Therapies
      • Advancing Computational and Structural Biology
      • Combating Drug Resistance
      • Developing Novel Imaging Techniques
      • Charting the Pathways of Inflammation
      • Zooming in on the Microbiome
      • Uncovering New Opportunities for Natural Products
      • Stimulating Neuroscience Research
      • Pursuing Precision Medicine
      • Unlocking the Potential of RNA Biology and Therapeutics
      • Producing Novel Vaccines
    • Research in Action
      • View All Stories
      • Too Much of a Good Thing
      • Turning Face Perception on Its Head
      • Safeguarding a Second Chance at Life
      • A Biological Betrayal
    • Trans-IRP Research Resources
      • Supercomputing
    • IRP Review Process
    • Commercializing Inventions
  • NIH Clinical Center
    • Clinical Center Facilities
    • Advancing Translational Science
    • Clinical Trials
      • Get Involved with Clinical Research
      • Physician Resources
  • News & Events
    • In the News
    • I am Intramural Blog
    • Speaking of Science Podcast
    • SciBites Video Shorts
    • The NIH Catalyst Newsletter
    • Events
  • Careers
    • Faculty-Level Scientific Careers
    • Trans-NIH Scientific Recruitments
      • Stadtman Tenure-Track Investigators
        • Science, the Stadtman Way
        • Earl Stadtman Investigator Frequently Asked Questions
      • Lasker Clinical Research Scholars
      • Independent Research Scholar
    • Scientific & Clinical Careers
    • Administrative Careers
  • Research Training
    • Program Information
    • Training Opportunities
    • NIH Work/Life Resources
The NIH Catalyst: A Publication About NIH Intramural Research

National Institutes of Health • Office of the Director | Volume 22 Issue 4 • July–August 2014

Extending Organ Survival

A Path Toward Animal-to-Human Transplants

BY CRAIG HICKS, NHLBI

Genetically modified pigs may one day offer new hope to thousands of people waiting for heart transplants, thanks in large part to an NIH intramural research team led by Muhammad Mansoor Mohiuddin at the National Heart, Lung, and Blood Institute (NHLBI).

“At any given time, about 3,000 people are on the waiting list for a heart transplant,” said Mohiuddin, who is chief of the Transplantation Section in NHLBI’s Cardiothoracic Surgery Research Program. “But only 2,000 donor hearts become available each year. Human organs alone will never be able to meet this demand.” Many people on the transplant waiting list will die before they receive a replacement heart, he said.

But one day, clinicians may be able to transplant pig hearts into people either as a substitute for human donor organs or as a “bridge” for patients awaiting a human heart transplant.

The use of animal organs in humans, or xenotransplantation, is a potential alternative to conventional transplantation of human donor organs. Artificial hearts might one day provide another alternative, but for now they pose risks such as blood clots, internal bleeding, infection, and mechanical malfunctions.

Pigs are an ideal animal source for xenotransplantation because their organs are similar in size to those of humans; there are fewer ethical issues because pigs are used for food; their breeding cycle is short; and it’s relatively easy to genetically modify them.

A significant obstacle, however, is that the pig and human immune systems are quite different, and a pig heart would be rejected within minutes. Mohiuddin and his team, however, are overcoming this barrier through a combination of genetic engineering and specialized drugs.

The genetic modifications allowed the researchers to use novel drugs to suppress parts of the immune system. These drugs avoid complications associated with traditional pharmacological approaches to preventing rejection, which suppress the entire immune system and put transplant recipients at greater risk for infection and disease.

 two surgeons performing an operation

ROBERT F. HOYT, NHLBI

NHLBI surgeon–researchers Muhammad Mohiuddin and Philip Corcoran perform a heart-transplantation procedure. Their work has extended pig-heart graft survival in baboons from mere minutes to 600 days.

The research team collaborated with Revivicor Inc., a Virginia-based regenerative-medicine company, to develop a three-part approach: knocking out certain pig genes for an antigen that stimulates an immune response; inserting a human gene, hCD46, into the pig to prevent activation of the recipient’s innate immune system that would otherwise kill foreign cells including those from a heart graft; and altering the genes responsible for proteins that prevent blood clots in pigs but are incompatible with human blood.

To test the pig hearts, the researchers placed each into a baboon’s abdomen and surgically connected two major blood vessels from the pig heart with two corresponding abdominal vessels in the baboon. Using this method, blood flows through all four chambers of the heart as well as its arteries and veins. The transplanted heart beats but doesn’t replace the baboon’s heart, which continues to function normally. This procedure allowed the researchers to overcome known obstacles from graft rejection while minimizing the risk to the baboons.

The baboon immune system is similar to that of humans and gives researchers the ability to assess whether new transplant techniques are promising enough for human testing. Ethical considerations, federal law, and NIH policy require responsible care and use of research animals. Mohiuddin’s team designed their studies to be sure the baboons survived even if the transplanted cardiac tissue was rejected.

In December 2013, Mohiuddin and his team were the first to demonstrate that interspecies transplanted hearts could survive more than a year in large animals; previously reported survivals of such transplanted hearts were less than four months (Am J Transplan 14:488–489, 2014 at http://onlinelibrary.wiley.com/doi/10.1111/ajt.12562/full).

In April 2014, they further reported survival of 600 days (J Thorac Cardiovasc Surg DOI:10.1016/j.jtcvs.2014.06.002 at http://dx.doi.org/10.1016/j.jtcvs.2014.06.002).

The next step, Mohiuddin said, is to fully replace a baboon’s original heart with a genetically engineered pig heart. If he and his intramural colleagues are successful, they could pave the way for xenotransplantation clinical trials for heart patients.


Others involved in the research: NHLBI: Keith Horvath, Avneesh Singh, Philip Corcoran, and Robert Hoyt; NHLBI Animal Surgery and Resources, Office of Research Services, Division of Veterinary Resources (DVR): Marvin Thomas, Michael Eckhaus, Tannia Clark, Billeta Lewis, and DVR technicians.

This page was last updated on Wednesday, April 27, 2022

  • Issue Overview
  • Features
    • NIH Microscopy Lights Up Dulles Airport
    • Human Motor Control
    • NIH’s First Intramural Early Independent Scientists
    • New Software Program Evaluates Potential for Metastasis
    • Extending Organ Survival
    • FelCom: Getting the Most Out of Your NIH Training Experience
  • Departments
    • From the Deputy Director for Intramural Research
    • Colleagues: Recently Tenured
    • Research Briefs
    • News You Can Use
    • The Training Page
    • From the Annals of NIH History
    • News Briefs
    • The SIG Beat
    • Announcements
  • Issue Contents
  • Download this issue as a PDF

Catalyst menu

  • Current Issue
  • Previous Issues
  • About The NIH Catalyst
  • Contact The NIH Catalyst
  • Share Your Story
  • NIH Abbreviations

Catalyst links

  • Follow The NIH Catalyst

Subscribe Today!

Subscribe to The NIH Catalyst Newsletter and receive email updates.

Subscribe

Get IRP Updates

Subscribe

  • Email
  • Print
  • Share Twitter Facebook LinkedIn

Main navigation

  • About Us
    • What Is the IRP?
    • History
    • Honors
    • Organization & Leadership
    • Our Programs
    • Research Campus Locations
    • Contact Information
  • Our Research
    • Scientific Focus Areas
    • Principal Investigators
    • Accomplishments
    • Accelerating Science
    • Research in Action
    • Trans-IRP Research Resources
    • IRP Review Process
    • Commercializing Inventions
  • NIH Clinical Center
    • Clinical Center Facilities
    • Advancing Translational Science
    • Clinical Trials
  • News & Events
    • In the News
    • I am Intramural Blog
    • Speaking of Science Podcast
    • SciBites Video Shorts
    • The NIH Catalyst Newsletter
    • Events
  • Careers
    • Faculty-Level Scientific Careers
    • Trans-NIH Scientific Recruitments
    • Scientific & Clinical Careers
    • Administrative Careers
  • Research Training
    • Program Information
    • Training Opportunities
    • NIH Work/Life Resources
  • Department of Health and Human Services
  • National Institutes of Health
  • USA.gov

Footer

  • Home
  • Contact Us
  • IRP Brand Materials
  • HHS Vulnerability Disclosure
  • Web Policies & Notices
  • Site Map
  • Search